Annual Secretarial Compliance Report for the year ended 31st March, 2025
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, as required under SEBI's Listing Regulations. The report, issued by Practicing Company Secretary M.C. Gupta & Co. (dated 12 May 2025), reviewed the company's compliance with SEBI Act, SCRA, LODR Regulations, Insider Trading rules, and other applicable SEBI regulations. The Practicing Company Secretary reported NIL observations, deviations, or penalties during the review period. The company confirmed compliance with all Secretarial Standards, timely policy updates, website disclosures, no disqualified directors, prior audit committee approval for related party transactions, and no action taken by SEBI or stock exchanges.
This is a routine regulatory filing with a clean compliance report and no adverse observations, indicating sound corporate governance practices. Neutral impact on the stock price, though it may reinforce investor confidence in the company's compliance standards.